Personalized dosage system (PDS)
Personalized dosage system is a system by which drugs are grouped by special doses to each patient, according to their dosage.SPD improves patient control, facilitates adherence to treatment, reduces errors in medication intake, avoids tampering and maintenance problems, and confusion and involuntary intoxication.
The dose of the medication is clearly differentiated by the days of the week and by the schedules. In addition, at the front of the SPD there is a label stating also the names of the non-solid drugs – jaws, injectables, ointments, etc., that have to be taken by the user and which can not be included in the blister pack as required Different maintenance conditions, and how they have to. Through this control can follow the rigorous pattern of each patient, the dosage, batch number and physical characteristics of them, to facilitate, if necessary, their identification. This new service has to be understood within the context of the longstanding demand made by the pharmaceutical professional to enhance his role as a health agent, in addition to being able to supply and regulate drugs in large quantities to hospitals and residences.
The implementation of individualized dosing systems in these countries has resulted in a very significant increase in the rate of compliance of treatments, reaching 80% compared to 31% that was achieved with traditional dispensing. All this has meant a saving in the cost of the health system, reducing the abandonment of medication and hospital admissions due to misuse of medicines.
Who is the SPD addressed to?
The advantages of SPD are evident, especially for certain types of users, for example, for those who daily undergo a treatment that includes three drugs, or for those who take decreasing, alternating or irregular doses.
It is the best option for the elderly, with difficulties to comply with treatment because of cognitive and manipulation problems as they are potential users of this new service offered by the pharmacy network with which they work in Farmadosis. You can benefit from this service all citizens who, expressly indicated by the prescribing doctor, so request.
The current profile of the patient within the SPD program is: Any patient with chronic diseases, polymedicines (3, 4 or more drugs), some of them following an irregular dosage and with a caregiver.
To access the SPD, a number of prerequisites must be fulfilled, starting with an in-depth interview between the pharmacist and the user. The user provides his personal data and explains in detail the treatments that follows. All of them are incorporated into a datasheet.
Subsequently, the data are entered into our management software that will allow the review of the treatment to rule out the incidents that may influence the process. All this process has a close relationship between the pharmacist and the general practitioner, not only to ratify all the data provided by the user, but also to facilitate communication in the event of incidences and changes in therapy.
We have presence in all the autonomous communities of the Spanish territory and we are a national reference about SPD SYSTEM
For health administration, the inclusion of the SPD in the practice of care can be an important improvement, since it has a significant impact on the reduction of the cost of non-compliance, as has been demonstrated in Canada, the United Kingdom and other countries. For example, in the US, costs for non-compliance or misuse of drugs exceed $ 76 billion per year. At the global level, the countries where the SPD is being developed are: Australia, Germany, Ireland, United Kingdom, New Zealand, USA, Canada and South Africa, among others.
The implementation of individualized dosing systems in these countries has resulted in a very significant increase in the compliance rate of treatments, reaching 80% compared to 31% achieved with traditional dispensing. All this has meant a saving in the cost of the health system, by reducing the dropouts of medication and hospital admissions for misuse of medicines.